DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Prostate tumors develop a unique epigenetic DNA methylation signature that is clonally maintained in disseminated metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Self-citationIntratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,045
Self-citationCyclical DNA methylation of a transcriptionally active promoter
Métivier, R., Gallais, R., Tiffoche, C., Le Péron, C., Jurkowska, R. Z., Carmouche, R. P., Ibberson, D., Barath, P., Demay, F., Reid, G., et al. (2008) · Nature · doi:10.1038/nature06544 · Cited by 900
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Self-citationEpigenetic inheritance during the cell cycle
Probst, A. V., Dunleavy, E., & Almouzni, G. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2640 · Cited by 795
Landscape of Somatic Retrotransposition in Human Cancers
Lee, E., Iskow, R., Yang, L., Gokcumen, O., Haseley, P., Luquette, L. J., Lohr, J. G., Harris, C. C., Ding, L., Wilson, R. K., et al. (2012) · Science · doi:10.1126/science.1222077 · Cited by 762
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 654
Self-citationTransient cyclical methylation of promoter DNA
Kangaspeska, S., Stride, B., Métivier, R., Polycarpou-Schwarz, M., Ibberson, D., Carmouche, R. P., Benes, V., Gannon, F., & Reid, G. (2008) · Nature · doi:10.1038/nature06640 · Cited by 636
Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer
Yegnasubramanian, S., Kowalski, J., Gonzalgo, M. L., Zahurak, M., Piantadosi, S., Walsh, P. C., Bova, G. S., De Marzo, A. M., Isaacs, W. B., & Nelson, W. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3972 · Cited by 527
Self-citationLuo, J., Duggan, D. J., Chen, Y., Sauvageot, J., Ewing, C. M., Bittner, M. L., Trent, J. M., & Isaacs, W. B. (2001) · PubMed · Cited by 485
Self-citationAlpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Walsh, P. C. (2002) · PubMed · Cited by 477
Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal
Hemberger, M., Dean, W., & Reik, W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2727 · Cited by 476
Purification of CpG islands using a methylated DNA binding column
Cross, S. H., Charlton, J. A., Nan, X., & Bird, A. P. (1994) · Nature Genetics · doi:10.1038/ng0394-236 · Cited by 442
Serre, D., Lee, B. H., & Ting, A. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp992 · Cited by 404
Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer
Schuebel, K. E., Chen, W., Cope, L., Glöckner, S. C., Suzuki, H., Yi, J.-M., Chan, T. A., Neste, L. V., Criekinge, W. V., Bosch, S. V. D., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030157 · Cited by 347
Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index
Feinberg, A. P., Irizarry, R. A., Fradin, D., Aryee, M. J., Murakami, P., Aspelund, T., Eiriksdottir, G., Harris, T. B., Launer, L., Gudnason, V., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001262 · Cited by 334
Self-citationCommon Gene Rearrangements in Prostate Cancer
Rubin, M. A., Maher, C. A., & Chinnaiyan, A. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.1916 · Cited by 307
Yegnasubramanian, S., Haffner, M. C., Zhang, Y., Gurel, B., Cornish, T. C., Wu, Z., Irizarry, R. A., Morgan, J., Hicks, J., DeWeese, T. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6088 · Cited by 294
Self-citationAn elaborate pathway required for Ras-mediated epigenetic silencing
Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C.-M., & Green, M. R. (2007) · Nature · doi:10.1038/nature06251 · Cited by 282
Role of DNA 5-Methylcytosine Transferase in Cell Transformation by fos
Bakin, A. V., & Curran, T. (1999) · Science · doi:10.1126/science.283.5400.387 · Cited by 238
Kobayashi, Y., Absher, D. M., Gulzar, Z. G., Young, S. R., McKenney, J. K., Peehl, D. M., Brooks, J. D., Myers, R. M., & Sherlock, G. (2011) · Genome Research · doi:10.1101/gr.119487.110 · Cited by 228
Regional Activation of the Cancer Genome by Long-Range Epigenetic Remodeling
Bert, S. A., Robinson, M. D., Strbenac, D., Statham, A. L., Song, J. Z., Hulf, T., Sutherland, R. L., Coolen, M. W., Stirzaker, C., & Clark, S. J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.006 · Cited by 201
Coolen, M. W., Stirzaker, C., Song, J. Z., Statham, A. L., Kassir, Z., Moreno, C. S., Young, A. N., Varma, V., Speed, T. P., Cowley, M., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2023 · Cited by 183
Eads, C. A., Nickel, A. E., & Laird, P. W. (2002) · PubMed · Cited by 181
Allele-specific DNA methylation: beyond imprinting
Tycko, B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq376 · Cited by 178
Deficiency of Mbd2 suppresses intestinal tumorigenesis
Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A., & Clarke, A. R. (2003) · Nature Genetics · doi:10.1038/ng1155 · Cited by 176
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
Peli, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1824 · Cited by 159
A Novel Role of Myosin VI in Human Prostate Cancer
Dunn, T. A., Chen, S., Faith, D., Hicks, J. L., Platz, E. A., Chen, Y., Ewing, C. M., Sauvageot, J., Isaacs, W. B., Marzo, A. M. D., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060316 · Cited by 154
Self-citationPrakash, K., Pirozzi, G., Elashoff, M., Munger, W., Waga, I., Dhir, R., Kakehi, Y., & Getzenberg, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112191399 · Cited by 124
Self-citationYegnasubramanian, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gnj022 · Cited by 100
Self-citationVisualization of genomic data with the Hilbert curve
Anders, S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp152 · Cited by 76
Yegnasubramanian, S., Wu, Z. J., Haffner, M. C., Esopi, D., Aryee, M. J., Badrinath, R., He, T. L., Morgan, J., Carvalho, B. S., Zheng, Q., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-313 · Cited by 73
Self-citationGenomic Imprinting, DNA Methylation, and Cancer
Rainier, S. R., & Feinberg, A. P. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.13.1028 · Cited by 50
Cited by
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Easwaran, H., Tsai, H.-C., & Baylin, S. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.015 · Cited by 915
“Therefore, despite the fact that focal promoter DNA hypermethylation is consistent between primary tumors and their metastatic counterparts (Aryee et al., 2013), the high error rate for replicating DNA methylation may indicate far more epigenetic than genetic variability occurs as tumors evolve.”
BackgroundAttard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Kumar, A., Coleman, I., Morrissey, C., Zhang, X., True, L. D., Gulati, R., Etzioni, R., Bolouri, H., Montgomery, B., White, T., et al. (2016) · Nature Medicine · doi:10.1038/nm.4053 · Cited by 738
Metadata
- Authors
- Aryee, M. J., Liu, W., Engelmann, J. C., Nuhn, P., Gurel, M., Haffner, M. C., Esopi, D., Irizarry, R. A., Getzenberg, R. H., Nelson, W. G., Luo, J., Xu, J., Isaacs, W. B., Bova, G. S., & Yegnasubramanian, S.
- Venue
- Science Translational Medicine
- Published
- 2013-01-23
- Volume
- 5
- Issue
- 169
- Pages
- 169ra10-169ra10
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2034879676
- Cited by
- 275
- References
- 56
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.